RNS Hotlist May 17: Ananda, Chaarat, Cellular, Hardide, Oxford Cannabinoid, Pantheon Resources
Ananda Developments plc (AQSE: ANA), a company whose ambition is to be a leading provider of cannabinoid-based medicines for the treatment of chronic, complex inflammatory